Ascend Wellness Holdings (AAWH) Operating Leases (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Operating Leases came in at $60.7 million in Q1 2026, up 6865.6% year-on-year from $872000.0 in Q1 2025, and down 80.41% quarter-over-quarter from $310.1 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Operating Leases (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Operating Leases history runs 7 years deep, the most recent figure standing at $60.7 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 6865.6% year-over-year to $60.7 million in Q1 2026; TTM through Mar 2026 was $60.7 million, a 6865.6% increase from a year earlier, with the FY2025 full-year figure at $310.1 million, up 12.38% from the prior year.
- Operating Leases eased to $60.7 million in Q1 2026 per AAWH's latest filing, from $310.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $310.1 million in Q4 2025 and bottomed at $872000.0 in Q1 2025.
- The 5-year median for Operating Leases is $263.0 million (2023), against an average of $220.3 million.
- Across the five-year window, Operating Leases jumped 12533.35% in 2023 and tumbled 99.67% in 2025, its largest moves.
- Year by year, Operating Leases stood at $229.8 million in 2022, then climbed by 15.94% to $266.4 million in 2023, then gained by 3.55% to $275.9 million in 2024, then increased by 12.38% to $310.1 million in 2025, then plunged by 80.41% to $60.7 million in 2026.
- Per Business Quant, the three latest AAWH Operating Leases figures stand at $60.7 million (Q1 2026), $310.1 million (Q4 2025), and $286.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.74 Mn |
| Dec 31, 2025 | 310.05 Mn |
| Sep 30, 2025 | 286.42 Mn |
| Jun 30, 2025 | 278.84 Mn |
| Mar 31, 2025 | 872,000.00 |
| Dec 31, 2024 | 275.90 Mn |
| Sep 30, 2024 | 272.54 Mn |
| Jun 30, 2024 | 271.26 Mn |
| Mar 31, 2024 | 262.70 Mn |
| Dec 31, 2023 | 266.44 Mn |
| Sep 30, 2023 | 262.99 Mn |
| Jun 30, 2023 | 265.55 Mn |
| Mar 31, 2023 | 245.71 Mn |
| Dec 31, 2022 | 229.82 Mn |
| Sep 30, 2022 | 229.84 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 223.98 Mn |
| Dec 31, 2021 | 197.30 Mn |
| Sep 30, 2021 | 199.83 Mn |
| Jun 30, 2021 | 174.49 Mn |